These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 12707269

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C, Auguste P, Chabbert M, Lelièvre E, Chevalier S, Gascan H.
    J Biol Chem; 2000 Feb 25; 275(8):5648-56. PubMed ID: 10681548
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D.
    J Biol Chem; 1996 Dec 20; 271(51):32635-43. PubMed ID: 8999038
    [Abstract] [Full Text] [Related]

  • 7. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 8. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
    Adrian-Segarra JM, Schindler N, Gajawada P, Lörchner H, Braun T, Pöling J.
    J Biol Chem; 2018 May 04; 293(18):7017-7029. PubMed ID: 29511087
    [Abstract] [Full Text] [Related]

  • 9. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F.
    J Immunol; 2000 Sep 01; 165(5):2535-43. PubMed ID: 10946280
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines.
    Aasland D, Schuster B, Grötzinger J, Rose-John S, Kallen KJ.
    Biochemistry; 2003 May 13; 42(18):5244-52. PubMed ID: 12731865
    [Abstract] [Full Text] [Related]

  • 11. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
    Ichihara M, Hara T, Kim H, Murate T, Miyajima A.
    Blood; 1997 Jul 01; 90(1):165-73. PubMed ID: 9207450
    [Abstract] [Full Text] [Related]

  • 12. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A, Pflanz S, Grötzinger J, Küster A, Kurth I, Pitard V, Heinrich PC, Müller-Newen G.
    FEBS Lett; 2000 Feb 25; 468(2-3):120-4. PubMed ID: 10692570
    [Abstract] [Full Text] [Related]

  • 13. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H.
    J Biol Chem; 2000 Aug 18; 275(33):25273-85. PubMed ID: 10854424
    [Abstract] [Full Text] [Related]

  • 14. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
    Smith DK, Treutlein HR.
    Protein Sci; 1998 Apr 18; 7(4):886-96. PubMed ID: 9568895
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cloning and characterization of a specific receptor for mouse oncostatin M.
    Lindberg RA, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA.
    Mol Cell Biol; 1998 Jun 18; 18(6):3357-67. PubMed ID: 9584176
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 18; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 19. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    J Clin Invest; 1995 Sep 18; 96(3):1319-27. PubMed ID: 7657807
    [Abstract] [Full Text] [Related]

  • 20. Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains.
    Taupin JL, Miossec V, Pitard V, Blanchard F, Daburon S, Raher S, Jacques Y, Godard A, Moreau JF.
    J Biol Chem; 1999 May 14; 274(20):14482-9. PubMed ID: 10318874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.